# プルヴィクト静注

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291481A1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291481A1029
- **Product name (Japanese):** プルヴィクト静注
- **Active ingredient:** ルテチウムビピボチドテトラキセタン（１７７Ｌｕ）
- **Strength / unit:** ７．４ＧＢｑ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Novartis Pharma (ノバルティス ファーマ)
- **NHI price (reference only):** JPY 3389878 per ７．４ＧＢｑ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291481A1029
- **JSON:** https://www.nifujipharma.com/api/drugs/4291481A1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=%E3%83%97%E3%83%AB%E3%83%B4%E3%82%A3%E3%82%AF%E3%83%88%E9%9D%99%E6%B3%A8%20%2F%20YJ%204291481A1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.
